Αναζήτηση
Αποτελέσματα 1-5 από 5
Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease
(2005)
Atherosclerosis is by far the leading cause of mortality and morbidity in patients with end stage renal disease undergoing chronic hemodialysis (HD). Vascular endothelial cell adhesion molecules like the intercellular ...
Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients
(2005)
Background/Aims: Insulin resistance is a well-known phenomenon in uremia. Resistin, a recently discovered insulin inhibitor secreted by adipocytes, is associated with obesity and insulin resistance in mice. Adiponectin, ...
Accidental acute metabolic acidosis due to inappropriate selection of bicarbonate concentrate
(2005)
Haemodialysis using a bicarbonate concentrate (bicarbonate dialysis) is the treatment modality of choice for correction of metabolic acidosis in chronic renal failure. However, improper ratios of acid and bicarbonate ...
Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery
(2005)
Background: Several effects of hemodialysis, including hemoconcentration, alterations of hemostasis or hemorheology and endothelial activation, could potentially interfere with cerebral blood flow (CBF) regulation. These ...
Effect of 1-year oral alpha-tocopherol administration on anticardiolipin antibodies in hemodialysis patients
(2005)
Background. Anticardiolipin antibodies (ACA) have been related to an increased incidence of thrombotic episodes and atherosclerosis progression. ACA levels are elevated in hemodialysis (HD) patients. Atheroembolic episodes ...